Pentetreotide
- Generic Name
- Pentetreotide
- Drug Type
- Small Molecule
- Chemical Formula
- C63H87N13O19S2
- CAS Number
- 138661-02-6
- Unique Ingredient Identifier
- G083B71P98
- Background
Pentetreotide has been used in trials studying the diagnosis of Cushing's syndrome.
- Associated Conditions
- Carcinoid Tumors, Gastroenteropancreatic Neuroendocrine Tumors
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Phase 2
Completed
- Conditions
- Cushing SyndromeEndocrine Disease
- Interventions
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Target Recruit Count
- 95
- Registration Number
- NCT00001849
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath